Although some reported that PD-1 inhibitors may have better efficacy than PD-L1 inhibitors and a higher incidence of pneumonitis that PD-L1 inhibitors [5], there is no strong evidence showing the superiority of one over the other. The gene discussed is CD274; the disease is pneumonitis.